medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2016, Number 4

<< Back Next >>

Rev ADM 2016; 73 (4)

Head and neck carcinomas, experience of a cancer center in the State of Durango, Mexico

Vargas-Soto O, Molina-Frechero N, Castañeda-Castaneira E, Bologna-Molina R, Carreón-Burciaga RG, González-González R

Language: Spanish
References: 19
Page: 190-196
PDF size: 257.76 Kb.


ABSTRACT

Introduction: Carcinomas of the head and neck are relatively common. They include different histological types and present a range of clinical characteristics, and are associated with diverse risks of mortality. Objective: To perform a casuistic review of cases of head and neck carcinomas over a period of five years at a State Cancer Center. Material and method: A retrospective study was conducted, in which risk factors and treatments were analyzed. Univariate and multivariate statistical analyses were performed for the purpose of evaluating prognostic and survival factors. Results: A total of 32 files were found to meet the criteria required by the study. Patient follow-up ranged from 2 to 32 months. The predominant histological variant identified was the squamous cell carcinoma, while the most common primary treatment was surgery. Conclusions: This study shows that survival from head and neck carcinomas decreases in patients who are in advanced clinical stages, particularly those of a certain age with a history of smoking and/or alcohol use, most of whom die from the progression and metastasis of the disease.


REFERENCES

  1. Kadri S, Uddin S, Ahmed N, Mahmood T. Malignant head and neck tumours in radiology department JPMC Karachi-a tertiary care experience. J Pak Med Assoc. 2015; 65 (8): 862-824.

  2. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol. 2009; 21: 194-200.

  3. Patel AN, Mehnert JM, Kim S. Treatment of recurrent metastatic head and neck cancer: Focus on cetuximab. Clin Med Insights Ear Nose Throat. 2012; 5: 1-16.

  4. Koontongkaew S. The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer. 2013; 4: 66-83.

  5. Pulte D, Brenner H. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist. 2010; 15: 994-1001.

  6. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC Cancer Staging Manual 7ª ed. New York, NY: Springer-Verlag, 2010.

  7. Safdari Y, Khalili M, Farajnia S, Asgharzadeh M, Yazdani Y, Sadeghi M. Recent advances in head and neck squamous cell carcinoma-a review. Clin Biochem. 2014; 47 (13-14): 1195-1202.

  8. Tirado L, Granados M. Epidemiología y etiología del cáncer de la cabeza y el cuello. Cancerología 2. 2007; 2: 9-17.

  9. Colevas AD. Chemotherapy options for patients with metastasic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol. 2006; 24: 2644-2652.

  10. Akhter M, Hossain S, Rahman QB, Molla MR. A study on histological grading of oral squamous cell carcinoma and its co-relationship with regional metastasis. J Oral Maxillofac Pathol. 2011; 15 (2): 166-176.

  11. Franceschini D, Paiar F, Saieva C, Bonomo P, Agresti B, Meattini I et al. Prognostic factors in patients with locally advanced head and neck cancer treated with concurrent radiochemotherapy. Radiol Med. 2016; 121 (3): 229-237.

  12. Honorato J, Rebelo MS, Dias FL, Camisasca DR, Faria PA, Azevedo E Silva G et al. Gender differences in prognostic factors for oral cancer. Int J Oral Maxillofac Surg. 2015; 44 (10): 1205-1211.

  13. Schwam ZG, Burtness B, Yarbrough WG, Mehra S, Husain Z, Judson BL. National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database. Cancer Med. 2015; 4 (12): 1828-1835.

  14. Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L et al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. 2015; 51: 2130-2143.

  15. Koirala K. Epidemiological study of laryngeal carcinoma in Western Nepal. Asian Pac J Cancer Prev. 2015; 16 (15): 6541-6544.

  16. Kumar R, Rai AK, Das D, Das R, Kumar RS, Sarma A et al. Alcohol and tobacco increases risk of high risk HPV infection in head and neck cancer patients: Study from North-East Region of India. PLoS One. 2015; 10 (10): e0140700.

  17. Radoï L, Menvielle G, Cyr D, Lapôtre-Ledoux B, Stücker I, Luce D et al. Population attributable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case-control study, the ICARE study. BMC Cancer. 2015; 15 (1): 827.

  18. Sharma A, Jagadesan P, Chaudhari P, Das S, Bhaskar S, Thakar A et al. Six years analysis of compliance to weekly Concurrent chemo-radiotherapy in head and neck carcinomas. Clin Otolaryngol. 2015; Epub ahead of print.

  19. Pignon JP, Maître A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomized trials and 17,346 patients. Radiother Oncol. 2009; 92: 4-14.




2020     |     www.medigraphic.com